Joint Whitepaper Explores Increase in DMR Tier III Adoption for Mission Critical Communications
Hytera, a leading provider of innovative Professional Mobile Radio (PMR) communications solutions, jointly announced the release of a new white paper entitled “DMR Trunked: Next Generation of LMR Technology” with IHS Markit, a global analysis firm specializing in the critical communications industry. The white paper outlines the steady growth and evolution path of DMR Tier III technology and provides a comprehensive analysis on its market demand and future adoption in vertical sectors such as Enterprise, Transportation, Utilities and Public Safety.
DMR Tier II conventional technology has traditionally been a business-critical technology, supplying communications for enterprise users. With the introduction of DMR Tier III trunking, the public safety and security markets are recognizing DMR as a viable technology for mission-critical applications. With a full complement of features designed with mission-critical users in mind, DMR Tier III trunking is gaining a global foothold in the Public Safety and security markets. By the year 2021, the Public Safety vertical is expected to account for nearly 35% of all DMR Tier III shipments worldwide.
According to the white paper, a key driver in the adoption of DMR technology is the rapid worldwide migration to digital technology. Historically, LMR (licensed mobile radio) communications technologies utilized analog operation. However, today’s LMR market is advanced, forward-thinking and fast-paced, with innovative technologies, concepts, and integrations hitting the market regularly. Recent technology announced by leading players for DMR Tier II, NXDN and dPMR have incorporated equipment supporting communications on both analog and digital networks – thus facilitating this transition. DMR Tier III technology has benefited from the transformation, growing as a competitive protocol for the Public Safety sector and becoming a mainstream technology for Utilities, Transportation, and Enterprise industries worldwide.
Convergence is anticipated to be the future of the critical communications industry. As more countries begin considering their roadmap to broadband LTE communications systems, hybrid solutions will form a large part of the transition economy. In short, LTE will complement critical voice with data, rather than replacing PMR altogether. With enhanced system design, security protection and encryption, DMR Tier III technology provide a clear evolution path to LTE migration in the form of a converged PMR + LTE solution, which will ultimately be required to make any LTE transition viable. A converged DMR and LTE solution includes a dual-mode radio which can connect to a cellular network in addition to the DMR network, which allows video uploading and video calls via the commercial network while connecting to the DMR network for mission and business-critical voice.
“Globally, the number of PMR users has continued to grow even as LTE emerges on the world stage. PMR, with its high resilience, low latency, instant one-to-many communications and rich feature set, will continue to provide mission-critical voice communications, while LTE supplements this capability with enhanced data services. One of the main drivers behind the growing PMR market is increasing digitization, with digital technology offering enhanced voice communications,” commented Ryan Darrand, Senior Analyst of IHS Markit. IHS Markit projects that the number of digital PMR users will nearly double between 2017 and 2021 bringing the total to 44 million active users. The number of digital PMR users exceeded the number of analog users for the first time in 2017 leaving a high number of analog users in the market. The availability of many digital standards including TETRA, P25, DMR, dPMR, NXDN, and PDT contribute to this growth from analog to digital. This growth trend is expected to continue between 2017 and 2021 as business-critical users in the developed world migrate to digital, and the popularity of trunked systems continue to appeal to mission-critical users.
“The PMR industry has been facing rapid development in recent years from analog to digital and from narrowband to broadband. Amid the substantial transformation, narrowband technologies like DMR Tier II and Tier III technologies played a critical role and provided vital linkages between those two epochal transitions,” said Ke Wang, General Manager of DMR System Development of Hytera Communications. “As a key player in DMR, Hytera has greatly pushed forward the development of DMR standard and popularized DMR technology all around the world in the past decade. By the end of 2017, Hytera has deployed over 8,000 base stations, and shipped more than 1 million trunked terminals, owning the largest market share as the market leader in the DMR Tier III segment. Our DMR Tier III solution has been widely adopted by Public Safety users in the world like Croatia Police, Turkey Police, Philippines National Police, Guatemala National Police and China Police, making it a reliable technology for mission-critical communications.”
For more information about the white paper, please visit -
About Hytera Communications
Hytera Communications Corporation Limited is a leading global provider of innovative professional mobile radio (PMR) communications solutions that improve organizational efficiency and make the world safer. Founded in Shenzhen, China in 1993 and listed on the Shenzhen Stock Exchange (002583.SZ), Hytera has ten research and development centers around the world. Hytera serves customers in over 120 countries and regions, including government, public security, utility, transportation, and enterprise. Sepura Group PLC and its subsidiary Teltronic S.A.U. became a part of Hytera in May, and Norsat International Inc. and its Sinclair Division became part of Hytera in July 2017. For more information, please visit www.hytera.com.
Hytera Communications Corporation Limited
Johnny Jian, +86 755 26972999
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
Samsung Sets New Photon Efficacy Level in White LED Packages for Indoor Farms23.4.2019 09:00:00 CEST | Pressemelding
Samsung Electronics Co., Ltd., a world leader in advanced digital component solutions, today announced an industry-leading enhancement to its mid-power LED package – the LM301H – for horticulture applications, such as greenhouse and vertical farming*. At 3.10 micromoles per joule (μmol/J), the newly introduced LM301H now features the highest photon efficacy** among today’s mid-power white LED packages. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190423005400/en/ Samsung Horticulture LED LM301H (Photo: Business Wire) “This breakthrough in photon efficacy will go a long way in helping indoor farm owners to maximize plant growth and quality, as well as their profits,” said Un Soo Kim, senior vice president of LED Business Team at Samsung Electronics. “We are committed to continue innovating white LED solutions optimized for healthier plant production as we solidify our leadership in the horticulture lighting industry.” As a
Vivet Therapeutics Announces 2 Abstracts Accepted for Oral Presentation at 2019 American Society of Gene and Cell Therapy Annual Meeting23.4.2019 08:38:00 CEST | Pressemelding
Vivet Therapeutics (“Vivet”), a privately held gene therapy biotech company dedicated to developing gene therapy treatments for inherited liver disorders with high unmet medical need, today announced that new data from its lead development program, VTX-801 a novel investigational gene therapy for WD, and VTX-803, Vivet’ novel therapeutic in development for the treatment of PFIC3, have been accepted for oral presentation during the ASGCT 22nd Annual Meeting, April 29 - May 2, 2019 in Washington, D.C., USA. Dr. Gloria González-Aseguinolaza, Vivet Therapeutics CSO & Head of the Gene Therapy Dept. at FIMA will present data from a recently completed study, validating in WD mice the use of fecal excretion of IV-injected 64copper as a pharmacodynamic endpoint in the VTX-801 Phase I/II trial currently under preparation. These data are the first demonstration of copper homeostasis restoration with 64Copper in an animal model of WD through the delivery of a single, intravenous administration of
Transphorm Centers on the Simplicity and Reliability of High Voltage GaN Application Development at PCIM 201923.4.2019 08:00:00 CEST | Pressemelding
Transphorm Inc.—the leader in the design and manufacturing of the highest reliability and first JEDEC- and AEC-Q101 qualified 650 V and 900 V gallium nitride (GaN) semiconductors—today shared a glimpse into its 2019 PCIM Europe showcase. Located in Hall 9 Booth 519, it centers on three key points to help conference attendees better understand Transphorm’s high voltage GaN value proposition: Reliability: Design with confidence when using Transphorm’s high quality, high reliability (Q+R) GaN transistors. Drivability: Pair Transphorm’s devices with off-the-shelf drivers, for easing drivability. Simplicity: Experience simpler designs due to minimal external gate drive circuitry along with standard packages, such as TO-220, TO-247, and PQFN, with well-known thermal management techniques. “At PCIM, you’ll see the culmination of Transphorm’s innovation along with its measurable impact on low volume as well as high volume customer applications,” said Philip Zuk, Vice President, Technical Marke
PV InfoLink to Host Dialogues with Industry Heavyweights on 2H19 Solar Market Outlook Prior To SNEC23.4.2019 07:00:00 CEST | Pressemelding
A seminar titled “2H19 PV Market Outlook and Forecast” will be held in Shanghai on June 3, one day prior to SNEC, to discuss global supply chain market outlook in the second half of this year. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190423005391/en/ 2019 Module Prices and Demand Forecast. (Photo: Business Wire) Held by PV InfoLink, a leading solar market intelligence provider, the seminar will bring together PV manufacturers, developers, EPC, and investors to explore major issues revolving the industry and help participants gain valuable insights for navigating the expanding solar market. PV InfoLink has invited Chinese major companies, including Jinko, Longi, and GCL-Si, to discuss impact of China’s transition to a subsidy-free market. This year, China’s demand will revive later than usual due to policy uncertainty. Moreover, Japan and India, China’s two major trading partners, saw weakening demand after the end of f
JPND Launches Updated Research and Innovation Strategy23.4.2019 06:45:00 CEST | Pressemelding
The EU Joint Programme – Neurodegenerative Disease Research (JPND) initiative 1 has launched its updated global Research and Innovation Strategy (RIS) , to provide a unified framework for the support of world class research into neurodegenerative diseases. Neurodegenerative diseases are one of the world’s leading medical and societal challenges and there are now expected to be 50 million people worldwide suffering from Alzheimer’s disease and related disorders. Globally, these numbers show no signs of abating, and it is estimated that by 2050 in Europe alone, the total direct and informal care costs for Alzheimer’s and Parkinson’s disease will exceed €350 billion annually.2 JPND is the first and largest collaborative research initiative established to tackle the growing challenge posed by neurodegenerative diseases. JPND’s ultimate goal is to accelerate the discovery of a cure and to enable early diagnosis for early personalised treatments. In the meantime, it is essential to implement
Comprehensive Tumor Profiling Promises New Therapeutic Options for Patients with Advanced Cancer22.4.2019 15:00:00 CEST | Pressemelding
Published in Nature Medicine* today, results of WINTHER, the first study pioneered by the WIN Consortium** - - Genomic and transcriptomic profiling expands precision cancer medicine: the WINTHER trial - shows that RNA profiling together with DNA testing matches more patients with advanced cancer to personalized therapies than DNA profiling for tumor mutations alone. The WINTHER trial***, NCT01856296, led by investigators from Vall d’Hebron Institute of Oncology - VHIO (Spain), Chaim Sheba Medical Center (Israel) (Raanan Berger), Gustave Roussy (France) (Jean-Charles Soria), Centre Léon Bérard (France) (Pierre Saintigny), Segal Cancer Centre, McGill University (Canada) (Wilson H. Miller), UT MD Anderson Cancer Center (USA) (Jordi Rodon and Apostolia-Maria Tsimberidou) and University of California San Diego, Moores Cancer Center (USA) (Razelle Kurzrock), aimed to expand precision oncology to patients with advanced solid tumors that progressed after treatment with standard therapies. For